Bronchiolitis: Assessment and evidence-based management

Medical Journal of Australia

Volumn 180, Issue 8, 2004, Pages 399-404

  Fitzgerald, Dominic ^a   Kilham, Henry A ^a  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANTIBIOTIC AGENT; BRONCHODILATING AGENT; CORTICOSTEROID DERIVATIVE; DEXAMETHASONE; IMMUNOGLOBULIN; INFUSION FLUID; OXYGEN; PALIVIZUMAB; PREDNISOLONE; RESPIRATORY SYNCYTIAL VIRUS ANTIBODY; RESPIRATORY SYNCYTIAL VIRUS VACCINE; RIBAVIRIN;

ARTICLE; BACTERIAL INFECTION; BLOOD CULTURE; BLOOD GAS ANALYSIS; BRONCHIOLITIS; CHILD; CHILDHOOD DISEASE; CLINICAL FEATURE; COUGHING; DISEASE SEVERITY; DRUG EFFICACY; EVIDENCE BASED MEDICINE; FEVER; HOME CARE; HOSPITAL ADMISSION; HUMAN; INFANT; INFANT DISEASE; MEDICAL ASSESSMENT; NEBULIZATION; POSITIVE END EXPIRATORY PRESSURE; PREMATURITY; RESPIRATORY DISTRESS; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RHINORRHEA; SUPERINFECTION; TACHYPNEA; THORAX RADIOGRAPHY; VIRUS CULTURE;

EID: 1942435945     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2004.tb05993.x     Document Type: Article

References (45)

1. Wohl ME, Chernick V. State of the art: bronchiolitis. Am Rev Respir Dis 1978; 118: 759-781.
2. Martinez FD. Respiratory syn virus bronchiolitis and the pathogenesis of childhood asthma. Pediatr Infect Dis J 2003; 22 (2 Suppl): S76-S82.
3. Lozano JM, Wang E. Bronchiolitis. Clin Evid 2002; 8: 291-303.
4. Black CP. Systematic review of the biology and medical management of respiratory syncytial virus infection. Respir Care 2003; 48: 209-233.
5. Turner SW, Young S, Landau LI, et al. Reduced lung function both before bronchiolitis at 11 years. Arch Dis Child 2002; 87: 417-420.
6. Martinez FD, Wright AL, Tuassing LM, et al. Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N Engl J Med 1995; 332: 133-138.
7. Frey U, Makkonen K, Wellman T, et al. Alterations in airway wall properties in infants with a history of wheezing disorders. Am J Respir Crit Care Med 2000; 161: 1825-1829.
8. Phelan P, Olinsky A, Robertson C. Clinical patterns of acute respiratory infections. Oxford: Blackwell Science, 1994: 52-93.
9. Roe M, O'Donnell DR, Tasker RC, Respiratory viruses in the intensive care unit. Paediatr Respir Rev 2003; 4: 166-171.
10. Martin AJ, Gardner PS, McQuillin J. Epidemiology of respiratory viral infection among paediatric inpatients over a six year period in north-east England. Lancet 1978; 2: 1035-1038.
11. Martinez FD. What have we learned from the Tucson Children's Respiratory Study? Paediatr Respir Rev 2002; 3: 193-197.
12. Cover RA, Spahn JD. Treating the wheezing infant. Pediatr Clin North Am 2003; 50: 631-654.
13. Mulholland EK, Olinsky A, Shann FA. Clinical findings and severity of acute bronchiolitis. Lancet 1990; 335: 1259-1261.
14. Navas L, Wang E, de Carvalho V, Robinson J. Improved outcome of respiratory syncytial virus infections in a high hospitalized population of Canadian children. J Pediatr 1992; 121: 348-354.
15. Wang EEL, Law BJ, Stephens D. Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) study of morbidity and risk factors with RSV disease. J Pediatr 1995; 126: 212-219.
16. Arnold SR, Wang EE, Law BJ, et al. Variable morbidity of respiratory syncytial virus infection in patients with underlying lung disease: a review of the PICNIC RSV database. Pediatric Investigators Collaborative Network on Infections in Canada. Pediatr Infect Dis J 1999; 18: 866-869.
17. National Health and Medical Research Council. How to use evidence: assessment and application of scientific evidence. Canberra: NHMRC, 2000. Available at: www.health.gov.au/nhmrc/publications/pdf/cp69.pdf (accessed Jan 2004).
18. Reynolds EOR. The effect of breathing 40 per cent oxygen on the arterial blood gas tensions of babies with bronchiolitis. J Pediatr 1963; 63: 1135-1139.
19. Kellner JD, Ohlsson A, Gadomski AM, Wang EE. Bronchodilators for bronchiolitis (Cochrance Review). In: The Cochrane Library, Issue 4, 2003. Chichester UK: John Wileys & Sons Ltd.
20. Covar RA, Spahn JD. Treating the wheezing infant. Pediatr Clin North Am 2003; 50: 631-654.
21. Richter H, Seddon P. Early nebulized budesonide in the treatment of bronchiolitis and the prevention of post-bronchiolitic wheezing. J Pediatr 1998; 132: 849-853.
22. Oommen A, Lambert PC, Grigg J. Efficacy of a short course of patient-initiated oral prednisolone for viral wheeze in children aged 1-5 years: randomised controlled trial. Lancet 2003; 362: 1433-1438.
23. Kini NM, Robbins JM, Kirschbaum MS, et al. Inpatients care for uncomplicated bronchiolitis. Arch Pediatr Adolesc Med 2001; 155: 1323-1327.
24. Krasinski K. LaCouture R, Holzman R, et al. Screening for respiratory syncytial virus and assignment to a cohort reduce nosocomial transmission. J Pediatr 1990; 116: 894-898.
25. Isaac D, Hickson H, O'Callaghan C, et al. Handwashing and cohorting in prevention of hospital acquired infections with respiratory syncytial virus. Arch Dis Child 1991; 66: 227-231.
26. Gala CL, Hall CB, Schnabel KC, et al. The use of eye goggles to control nosocomial respiratory syncytial infection. JAMA 1986; 256: 2706-2708.
27. Hall CB, Douglas RG. Nosocomial respiratory syncytial virus infections: should gowns and masks be used? Am J Dis Child 1981; 135: 512-515.
28. Murphy D, Todd JK, Chao RK, et al. The use of gowns and mask to contain respiratory illness in pediatric hospital personnel. J Pediatr 1981; 99: 746-750.
29. Henry R, Milner AD, Stokes GM. Ineffectiveness of ipratropium bromide in acute bronchiolitis. Arch Dis Child 1983; 58: 925-926.
30. Seidenberg J, Masters B, Hudson A, et al. Effect of ipratropium bromide on respiratory mechanics in infants with acute bronchiolitis. Aust Paediatr J 1987; 23: 169-172.
31. Wang EEL, Milner R, Allen U, Maj H. Bronchiolilators for treatment of mild bronchiolitis: a factorial randomised trial. Arch Dis Child 1992; 289: 289-293.
32. Everard ML, Kurian M. Anti-cholinergic therapy for treatment of wheeze in children under the age of two years. In: The Cochrane Library, Issue 4, 1998. Oxford: Update Software.
33. Garrison MM, Christiakis DA, Harvey E, et al. Systemic corticosteroids in infant bronchiolitis: a meta-analysis. Pediatr 2000; 105: E44.
34. Schula S, Coates AL, Binnie R, et al. Efficacy of oral dexamethasone in outpatients with acute bronchiolitis. J Pediatr 2002; 140: 27-32.
35. Barben JU, Robertson CF, Robinson PJ. Implementation of evidence based management of acute bronchiolitis. J Pediar Child Health 2000; 36: 491-497.
36. Wainwright CE, Altamirano L, Chenney M, et al. A multicenter, randomized, double-blind, controlled trial of nebulized epinephrine in infants with acute bronchiolitis. N Engl J Med 2003; 349: 27-35.
37. Randolph AG, Wang EEL. Ribavirin for respiratory syncytial virus infection of the lower respiratory tract. In: The Cochrane Library, Issue 4, 2003, Chichester, UK: John Wiley & Sons Ltd.
38. Decker JA, Seitz TA, Shults RA, et al. Occupational exposures to aerosolized pharmaceuticals and control strategies. Scand J Work Environ Health 1992; 18: 100-102.
39. Wheeler JG, Wofford J, Turner RB. Historical cohort evaluation of ribavirin efficacy in respiratory syncytial virus infection. Pediatr Infect Dis J 1993; 12: 209-213.
40. Friis B, Andersen P, Brenoe E, et al. Antibiotic treatment of pneumonia and bronchiolitis. A prospective randomised study. Arch Dis Child 1984; 59: 1038-1045.
41. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respitory syncytial virus infection in high-risk infants. The IMpact RSV study group. Pediatrics 1998; 102: 531-537.
42. Numa A. Outcome of respiratory syncytial virus infections and a cost-benefit analysis of prophylaxis. J Paediatr Child Health 2000; 36: 422-427.
43. Reduction of respiratory syncytial virus hospitalization among premature infants and infants with bronchopulmonary dysplasia using respiratory syncytial virus immune globulin prophylaxis. The PREVENT study group. Pediatrics 1997; 99: 93-99.
44. Johnson S, Oliver C, Prince GA, et al. Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus. J Infect Dis 1997; 176: 1215-1224.
45. Wang EEL, Tang NK. Immunoglobulin for preventing respiratory syncytial virus infections. In: The Cochrane Library, Issue 4, 2003, Chichester, UK. John Wiley & Sons Ltd.